Bio-Path Holdings Inc (BPTH)
2.69
+0.06
(+2.09%)
USD |
NASDAQ |
Apr 26, 16:00
2.69
0.00 (0.00%)
After-Hours: 19:09
Bio-Path Holdings Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2007 | 0.00% |
| March 31, 2007 | 0.00% |
| December 31, 2006 | -12.03% |
| September 30, 2006 | -7.82% |
| June 30, 2006 | 17.24% |
| March 31, 2006 | 6.21% |
| Date | Value |
|---|---|
| December 31, 2005 | -19.23% |
| September 30, 2005 | 19.70% |
| June 30, 2005 | 23.47% |
| March 31, 2005 | 30.19% |
| December 31, 2004 | 16.25% |
| September 30, 2004 | 29.57% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 92.89% |
| INVO Bioscience Inc | 35.82% |
| SINTX Technologies Inc | 23.67% |
| Aileron Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 48.70% |